Sarah Croughan Thompson serves as Executive at BlackRock ESG Capital Allocation Term Trust, where they oversee executive responsibilities. Since joining the company, Sarah Croughan Thompson has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 30, 2026 involved exercising options for 693.85 shares valued at $0.
Sarah Croughan Thompson currently holds 1,387.7 shares of BlackRock ESG Capital Allocation Term Trust (ECAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sarah Croughan Thompson has been a net neutral trader of ECAT stock. They have purchased $0 and sold $0 worth of shares.
Sarah Croughan Thompson's most recent insider trade was on Jan 30, 2026, when they sold 693.85 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $14.70 |
| Discretionary |
| Jan 30, 2026 | BCAT | $0 | Option Exercise | 693.85 | $N/A | Discretionary |
| Jan 30, 2026 | ECAT | $0 | Option Exercise | 642.37 | $N/A | Discretionary |
| Jan 30, 2026 | ECAT | $9.9K | Disposition | 642.37 | $15.44 | Discretionary |
| Jan 30, 2026 | ECAT | $0 | Option Exercise | 642.37 | $N/A | Discretionary |